Discontinued — last reported Q4 '23
Idexx Laboratories Other — Total Revenue remained flat by 0.0% to $26.03M in Q4 2023 compared to the prior quarter. Year-over-year, this metric grew by 8.1%, from $24.07M to $26.03M. Over 2 years (FY 2021 to FY 2023), Other — Total Revenue shows an upward trend with a 7.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates successful expansion into new markets or growing demand for secondary product lines, while a decrease may signal market saturation or a strategic shift away from these areas.
This metric represents the total revenue generated by the company's 'Other' business segment, which encompasses geograph...
Peers often report similar 'Other' or 'Rest of World' segments, though the composition varies significantly based on how a company defines its core versus non-core operations.
idxx_segment_other_total_revenue| FY'21 | FY'22 | FY'23 | |
|---|---|---|---|
| Value | $89.52M | $96.29M | $104.11M |
| YoY Change | — | +7.6% | +8.1% |